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Key points 35 
 36 
Both maximal oxygen uptake (V̇O2max) and body composition are predictive of cardiovascular disease and 37 
mortality. V̇O2max is typically scaled to body size but there is disagreement over the value of the size 38 
exponent for both of the most commonly-studied variables of body mass and fat-free mass. 39 
 40 
In this first formal quantitative synthesis of human studies, the fat-free mass exponent was 0.90 (95% 41 
prediction interval: 0.68 to 1.12) and found to be independent of sex.  42 
 43 
The probability that the fat-free mass exponent in a future study would be higher than the ⅔- and ¾-power 44 
laws was estimated to be 0.98 (very likely) and 0.92 (likely), respectively.  45 
 46 
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Abstract 75 
 76 
Background: Maximal oxygen uptake (V̇O2max) is conventionally normalized to body size as a simple ratio 77 
or using an allometric exponent < 1. Nevertheless, the most appropriate body size variable to use for 78 
scaling and the value of the exponent are still enigmatic. Studies tend to be based on small samples and 79 
can, therefore, lack precision.   80 
 81 
Objective: To provide a quantitative synthesis of reported static allometric exponents used for scaling 82 
V̇O2max to whole body mass and fat-free mass. 83 
 84 
Methods: Eight electronic databases (CINAHL, Cochrane Central Register of Controlled Trials, EMBASE, 85 
MEDLINE, PubMed, Scopus, SPORTDiscus and Web of Science) were searched for relevant studies 86 
published up to January 2016. Search terms included ‘oxygen uptake’, ‘cardiorespiratory fitness’, 87 
‘V̇O2max’, ‘V̇O2peak’, ‘scaling’ and all interchangeable terms. Inclusion criteria included human 88 
cardiorespiratory fitness data; cross-sectional study designs; an empirical derivation of the exponent; 89 
reported precision statistics; and reported information regarding participant sex, age and sports background, 90 
V̇O2max protocol, body composition protocol and line-fitting methods. A random-effects model was used to 91 
quantify weighted pooled exponents and 95% confidence limits (95% CL). Heterogeneity was quantified 92 
with the tau-statistic (τ). Meta-regression was used to quantify the impact of selected moderator variables 93 
on the exponent effect size. A 95% prediction interval (95% PI) was calculated to quantify the likely range 94 
of true fat-free mass exponents in similar future studies, with this distribution used to estimate the 95 
probability that an exponent would be above theorised universal values of ⅔ and ¾. 96 
 97 
Results: Thirty-six studies, involving 6,514 participants, met the eligibility criteria. Whole-body mass and 98 
fat-free mass was used as the scaling denominator in 27 studies and 15 studies, respectively. The pooled 99 
allometric exponent (95% CL) was found to be 0.70 (0.64 to 0.76) for body mass and 0.90 (0.83 to 0.96) 100 
for fat-free mass. The between-study heterogeneity was greater for whole-body mass (τ = ± 0.15) vs. fat-101 
free mass (τ = ± 0.11). Participant sex explained 30% of the between-study variability in the whole-body 102 
mass exponent, but the influence on the fat-free mass exponent was trivial. The body mass exponent of 103 
0.52 (0.40 to 0.64) for females was substantially lower than the 0.76 (0.70 to 0.83) for males, whereas the 104 
fat-free mass exponent was similar for both sexes. The effects of all other moderators were trivial. The 105 
95% PI for fat-free mass ranged from 0.68 to 1.12. The estimated probability of a true fat-free mass 106 
exponent in a future study being greater than ⅔- or ¾-power scaling is 0.98 (very likely) and 0.92 (likely), 107 
respectively.  108 
 109 
Conclusions: In this quantitative synthesis of published studies involving over 6,500 humans, the body 110 
mass exponent was found to be spuriously low and prone to substantial heterogeneity. We conclude that 111 
the scaling of V̇O2max in humans is consistent with the allometric cascade model with an estimated 112 
prediction interval for the fat-free mass exponent not likely to be consistent with the ⅔ and ¾ power laws. 113 
 114 
 4 
1   Introduction 115 
 116 
Maximal oxygen uptake (V̇O2max), sometimes referred to as “peak” oxygen uptake (V̇O2peak) in 117 
young [1] and pathophysiological populations [2], is a well-established indicator of cardio-metabolic health 118 
and a strong prognostic factor for all-cause mortality [3]. V̇O2max is also a key indicator of top-class sports 119 
performance, especially in cross-country skiers, endurance cyclists, marathon runners and football (soccer) 120 
players [4-7]. V̇O2max is typically expressed in absolute values or as a simple ratio to body size. In recent 121 
systematic reviews and meta-analyses, the effects of training interventions on V̇O2max, either in a healthy, 122 
clinical or sports population, were quantified in absolute terms or per kg of body weight [8-11]. This 123 
ratiometric index is statistically robust only if there is a direct proportional relationship between numerator 124 
and denominator, an underlying assumption that is seldom confirmed in nature [12]. Therefore, the 125 
inherent theoretical, mathematical and empirical flaws of ratios render them unsuitable to normalize 126 
physiological data [13]. These shortcomings of ratios have led many scientists to consider alternative 127 
approaches based on power-law constructs in an attempt to partition out the confounding effects of body 128 
size [14-17]. Nevertheless, indices of V̇O2max normalized to power law-based exponents could yet display a 129 
residual size correlation [18, 19]. Allometric scaling approaches are accurate only if the correlation 130 
between the normalized index and the size variable approaches zero [20]. 131 
Whole-body mass is the conventional scaling denominator of V̇O2max, particularly in interspecific 132 
allometry studies. Interspecific allometry refers to differences in morphological, physiological or 133 
ecological traits between different species when measured at the same growth stage, whereas intraspecific 134 
allometry defines how the traits of individuals within a single species alter at, for example, different ages 135 
[21]. When the allometric exponents are quantified in human studies, values appear to fall into one of two 136 
“camps” corresponding to the ⅔ or ¾ power scaling laws [22-25]. The majority of these studies also tend 137 
toward small sample sizes (n < 60), resulting in relatively imprecise estimates of the exponent due to 138 
sampling error [26]. As such, the spectrum of findings for the whole-body mass exponent limits the 139 
definition of the exact power function for the scaling of V̇O2max in human samples. The current uncertainty 140 
might also reflect the lack of information on relevant covariates in the model. The absence of intra-species 141 
variation, quantified as differences in V̇O2max, age, sex, body composition, is somewhat unrealistic [27]. 142 
While in interspecific allometry the large body size range overwhelms between-individual variability in 143 
other prognostic variables, careful model adjustment (e.g. for body composition) is essential in intraspecific 144 
studies that inevitably have a curtailed size range [28].  145 
The fundamental validity of scaling human energy metabolism to whole-body mass was itself 146 
challenged more than half-century ago [29, 30]. Indeed, fat-free mass, on physiological grounds, is 147 
arguably a more appropriate scaling denominator for V̇O2max, as over 90% of the oxygen passing through 148 
the lungs of an exercising mammal is destined for a single sink in the skeletal muscle mitochondria [23, 149 
31]. Some scientists have reported a substantial difference in the allometric exponents for whole-body mass 150 
and fat-free mass, with the latter being observed to be closer to unity [23, 32]. Nevertheless, most of these 151 
studies, again, involve relatively small sample sizes, which lead to wide confidence limits for each 152 
exponent estimate [33-37].  153 
To date, there is no published quantitative synthesis of all the derived size-exponents to clarify if 154 
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the relationship between V̇O2max and body size equates to a universal scaling exponent within a large, 155 
heterogeneous human sample of males and females. To improve statistical precision and ultimately help to 156 
resolve some inconsistencies in the literature, we aim to provide a quantitative synthesis of derived static 157 
allometric exponents for the scaling of V̇O2max to whole-body mass and fat-free mass. 158 
 159 
2   Methods 160 
 161 
2.1   Study eligibility 162 
 163 
2.1.1   Inclusion criteria 164 
 165 
The primary outcome measure was the estimated static allometric exponent (b) for whole-body 166 
mass and fat-free mass to scale V̇O2max. To be selected for quantitative synthesis, studies had to meet all of 167 
the following criteria: i) V̇O2max data were gathered directly in human samples during maximal 168 
cardiopulmonary exercise testing; ii) the investigation had a cross-sectional design; iii) the allometric 169 
exponent was originally derived from the examined sample; iv) either confidence limits (CL), standard 170 
deviation (SD), standard error (SE) or Pearson’s correlation coefficient (r) for the allometric model were 171 
reported; v) details relevant to the identified moderator variables were outlined. The target population had 172 
no restriction.  173 
 174 
2.1.2   Exclusion criteria 175 
 176 
Studies were excluded if: i) ontogenetic allometry was the primary analysis; ii) static exponents 177 
were derived from a longitudinal or mixed-longitudinal study; iii) power function scaling was not 178 
performed; iv) power law-based exponents were adopted a priori rather than being derived empirically; v) 179 
sample and results matched a previous publication (duplication); vi) the full-text manuscript was written in 180 
languages other than English. 181 
 182 
2.2   Literature search and study selection 183 
 184 
Electronic searching was performed across eight databases (CINAHL, Cochrane Central Register 185 
of Controlled Trials, EMBASE, MEDLINE, PubMed, Scopus, SPORTDiscus and Web of Science) and 186 
conducted by two of the authors (LL, GA) from October 2015 to January 2016. Search terms included 187 
“oxygen uptake” OR “oxygen consumption” OR “aerobic power” OR “aerobic fitness” OR 188 
“cardiorespiratory fitness” OR “cardio?respiratory fitness” OR “V̇O2peak” OR “peakV̇O2” OR 189 
“V̇O2max” OR “maxV̇O2” OR “V̇O2?peak” OR “peak?V̇O2” OR “V̇O2?max” OR “max?V̇O2” OR 190 
“cardiorespiratory function” OR “cardio?respiratory function” OR “exercise capacit*” OR “physical 191 
fitness” OR “functional capacit*” OR “exercise performance*” AND “allomet*” OR “exponent” OR 192 
“exponents” OR “scaling” OR “scaled” either singly or in combination. Additional records were obtained 193 
from the reference lists of the retrieved articles or by hand searching. Only investigations conducted in 194 
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humans were considered. All titles and abstracts were initially scrutinized to exclude studies that were 195 
beyond the aim of this meta-analysis. The remaining full-text-articles that met each of the eligibility criteria 196 
were then included in quantitative synthesis. Disagreements were resolved with the aid of a third reviewer 197 
(KLW). A complete overview of the process is illustrated in Fig. 1. The systematic literature review was 198 
conducted in compliance with the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-199 
analyses) statement [38].  200 
 201 
2.3   Data extraction 202 
 203 
DigitizeIt (Braunschweig, Germany), graph digitizer software, was used in the cases where only 204 
plots were available for descriptive data. Study characteristics, pooled value of the allometric exponent and 205 
respective statistical precision measures were extracted by two authors (LL, GA). If precision measures 206 
were not reported, standard errors were derived via the relationship between the standard deviation of the 207 
primary outcome (i.e. V̇O2max expressed in L·min-1) and Pearson’s correlation coefficient for the allometric 208 
model. Data relevant to age category (i.e. cut-off point for adults: mean age ≥ 18 years), sports background, 209 
sex, physical testing, body composition assessment method for determining fat-free body mass (i.e. greater 210 
precision means: dual-energy X-ray absorptiometry; lower precision means:  bioelectrical impedance 211 
analysis), and line-fitting methods were obtained to evaluate the potential effects of the identified 212 
moderator variables on the global allometric exponent. Disagreements over the accuracy and 213 
comprehensiveness of the extracted data were resolved with the aid of KLW. Descriptive statistics for 214 
studies included in the meta-analysis are shown in Table 1. 215 
 216 
Figure 1 about here 217 
 218 
2.4   Statistical analysis  219 
 220 
A random-effects model was selected on the basis of the methodological diversity across the 221 
studies [39]. Weighted raw point estimate and 95% confidence limits (95% CL) were calculated as 222 
summary statistics. Among-studies heterogeneity was quantified with the Tau statistic (τ) – a standard 223 
deviation describing the typical variability in the mean size-exponent between studies [40]. We derived a 224 
95% prediction interval (95% PI) to quantify the expected range of true exponents for 95% of similar 225 
future studies [41]. This dispersion of true effects was then used together with the t-distribution [41] to 226 
estimate the probability of the true size-exponent in new studies being above the theoretical values of ⅔- or 227 
¾-power, respectively. The observed probabilities were interpreted according to the following scale: 228 
<0.5%, most unlikely; 0.5-5 %, very unlikely; 5-25 %, unlikely; 25-75 %, possible; 75-95 %, likely; 95-229 
99.5 %, very likely; >99.5 %, most likely [42]. A meta-regression analysis was performed to assess the 230 
impact of each moderator on the estimated exponent. Small study bias was examined through Egger’s test 231 
[43]. All statistical analyses were conducted using Comprehensive Meta-analysis software, version 3 232 
(Biostat Inc., Englewood, NJ, USA).  233 
Table 1 about here 234 
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3   Results  235 
 236 
3.1   Study selection 237 
 238 
Overall, 36 studies met the eligibility criteria out of 3,487 abstracts. The ultimate dataset also 239 
encompassed baseline values from two clinical trials conducted in a group of thirty obese boys and eighty-240 
four adolescent girls, respectively [48, 52]. In addition to this, one time-based cross-sectional analysis of 241 
mixed-longitudinal study data, within a small sample of youth football players, was also extracted [36]. In 242 
one study [55], allometric exponents were quantified for fat-free mass measured using both dual-energy X-243 
ray absorptiometry (DXA) and sum-of-skinfolds methods on the same samples of males and females. 244 
Being aware of the important issue of double counting in meta-analysis [68], we selected the DXA-derived 245 
data since it represents a criterion method for measuring body composition [69, 70]. Nevertheless, the 246 
overall pooled exponent, confidence limits, and prediction interval were found to be unaffected in the 247 
sensitivity analysis we undertook using the skinfolds-derived data from the above-quoted study. Likewise, 248 
we extracted distinct body mass [23] and fat-free mass [44] exponents derived from modeling V̇O2max in 249 
two different studies with substantially overlapping sample characteristics (Table 1). Conversely, 17 250 
investigations were dismissed because of the missing model precision statistics (i.e. 95% CL; SD; SE; 251 
Pearson’s r), one due to lack of relevant information for each selected moderator and another study in 252 
which healthy and clinical subjects were combined. 253 
The identified cohort of studies summarizes thirty-two years of research published between 1984 254 
and 2016. The derived allometric exponents were dichotomized into two main domains relevant to whole-255 
body mass (n = 27) and fat-free mass (n = 15) respectively (Fig. 2). The whole sample involved 6,514 256 
humans. The observed size range was 57.2 kg (30.1 to 87.3). 257 
 258 
Figure 2 about here 259 
 260 
3.2   Study outcomes  261 
 262 
3.2.1   Body mass  263 
 264 
The meta-analysed exponent for whole-body mass (Fig. 2a) was found to be 0.70 (0.64 to 0.76). 265 
Substantial heterogeneity was observed, with the tau statistic being ± 0.150. A meta-regression revealed a 266 
substantial sex difference in the body mass exponent of 0.24 (0.11 to 0.38), with an observed magnitude of 267 
0.76 in males and 0.52 in females. When sex was included in the full model as a moderator, tau reduced to 268 
± 0.126. Sex accounted for 30% of the between-study variability in exponents (Table 2). None of the other 269 
moderators we examined explained a substantial proportion of between-study variance in mass exponent. 270 
The positive Egger’s regression coefficient (intercept) of 1.35 (-0.34 to 3.05) suggested a small study bias, 271 
whereby studies involving small samples tend to have larger exponents (Fig. 3). 272 
 273 
 274 
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3.2.2   Fat-free mass  275 
 276 
The pooled allometric exponent for fat-free mass (Fig. 2b) was 0.90 (0.83 to 0.96). The observed 277 
degree of heterogeneity between studies (τ = ± 0.11) was lower than that found for whole-body mass. The 278 
95% PI for the fat-free mass exponent was estimated to be 0.68 to 1.12. The estimated probability in a 279 
future study for the true fat-free mass exponent being above ⅔- or ¾-power scaling is 0.98 (very likely) 280 
and 0.92 (likely), respectively. The meta-regression results indicated that none of the explored moderators 281 
had a substantial influence on the fat-free mass exponent (Table 3).  282 
There was no trend for small study bias in the fat-free mass study cohort (Fig. 4), with Egger’s 283 
coefficient being 0.38 (-1.11 to 1.87). 284 
 285 
Table 2 about here 286 
Table 3 about here 287 
Figure 3 about here 288 
Figure 4 about here 289 
 290 
4   Discussion  291 
 292 
The substantial proportion of unexplained between-study variance in the mean b estimates 293 
indicates that the notion of a constant generalizable exponent is untenable. The observed degree of 294 
heterogeneity (τ) reflects systematic differences between the empirically-derived size-exponents in the 295 
synthesised literature. The pooled estimated exponent for whole-body mass we derived (Fig. 2a) was 296 
approximately midway between the hypothesised ⅔ and ¾ power laws for the scaling of V̇O2max to whole-297 
body mass [71, 72]. Conversely, the mean of the distribution of the more physiologically-relevant fat-free 298 
mass exponent (Fig. 2b) was consistent with the predictions of the allometric cascade model [73]. 299 
According to this observation, we consider it important to emphasise here the correct 300 
interpretation of the random-effects meta-analysis. The 95% confidence limits quantify the uncertainty in 301 
the pooled mean of systematically different exponents reported in the studies, and do not quantify the 302 
heterogeneity [39]. Rather, the 95% PI (0.68 to 1.12) we calculated is now the preferred approach to 303 
account for both the variance of the pooled estimate (SE2) and the between-study heterogeneity (τ2). The 304 
95% PI essentially quantifies the likely range for the true fat-free mass exponent that might be expected in 305 
future settings [41]. If the between-study heterogeneity was observed to be zero, then the 95% PI would 306 
equate to the respective 95% CL for the summary effect [41]. Given the between-study heterogeneity we 307 
found in this quantitative synthesis of the literature, the probability of the fat-free mass exponent in a future 308 
study being higher than the theorised ⅔ or ¾ power laws is 0.98 (very likely to be greater) and 0.92 (likely 309 
to be greater), respectively. 310 
Importantly, in our meta-analysis, we have included estimates of size-exponents derived 311 
in independent groups (e.g. males and females; athletes and non-athletes; different age categories) both in 312 
different studies and also within the same study [55, 63, 67]. However, the random-effects model assumes 313 
the same variation in true exponents within the study and across studies, which might not apply [74]. 314 
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Therefore, we performed a sensitivity analysis, for the fat-free mass exponent only, by conducting a 315 
random-effects meta-analysis of those studies that derived an exponent in a single group (N = 11). In this 316 
analysis, the pooled fat-free mass exponent was 0.90 (0.81 to 0.98), with a 95% PI of 0.66 to 1.14. The 317 
probability that the effect in a similar future study will be greater than ⅔- and ¾-power is 0.97 (very likely) 318 
and 0.90 (likely), respectively. The sensitivity analysis thus revealed that our original inference was robust, 319 
and not materially affected by including multiple independent samples within studies. 320 
The a priori assumption of a universal rate-limited process hinders our understanding of the 321 
allometry of V̇O2max [75]. The assumption dictates that energy metabolism increases to a fixed rate with 322 
whole-body mass, irrespective of an individual’s metabolic state [71, 72]. This direct relationship has been 323 
supported only by studies on hibernating animals [75]. If a single-rate limiting process regulates aerobic 324 
metabolism, there would be no room left for metabolic scope from resting state to higher exercise 325 
intensities [76]. Moreover, body size range is an essential determinant for the precision of the exponent 326 
estimate [77]. Interspecific allometry studies provided evidence about the variations in maximal aerobic 327 
capacity by quantifying the size-induced effects per se. The broad size range reported in those studies (e.g. 328 
mouse-to-elephant) supports such a scaling regimen, although certain aspects of metabolic scaling may be 329 
concealed or even vary substantially at finer phyletic levels [77]. Our large-scale data highlight the 330 
importance of adjusting for relevant covariates since the relatively small size range from 30.1 to 87.3 kg is 331 
inadequate to overwhelm the sources of between-subject variability in V̇O2max [28], conversely to what is 332 
observed in interspecific allometry [78]. 333 
This large-scale evidence synthesis confirms that, from a physiological perspective, fat-free mass, 334 
and not whole-body mass, should be considered the most appropriate scaling denominator for V̇O2max [79, 335 
80]. The canonical models dealt with the constraints of body size on Euclidean and biological grounds [71, 336 
72]. The fractal geometry model implies a direct proportional relationship between blood volume and 337 
whole-body mass [81]. However, this fractal model does not consider the haemodynamic responses during 338 
exercise [80]. There is evidence to indicate that the metabolically active tissues dictate the regulation of 339 
supply and demand [31]. The redistribution of blood flow from resting state to maximal exercise intensity 340 
is well-documented in animal and human studies [82, 83], in which the systemic delivery converges to 341 
match the aerobic demands at the regional level, particularly for skeletal muscle [84]. It is thus paramount 342 
to consider the body compartments that contribute to the overall metabolic rate at a given exercise 343 
intensity.  344 
Due to the substantial heterogeneity of body composition, whole-body mass is not a robust scaling 345 
denominator as it fails to reflect the real physiological processes during incremental exercise [30, 85, 86]. 346 
Indeed, Graves et al. [69] highlighted the superior fit of allometric models that incorporate fat-free mass, 347 
rather than whole-body mass, for scaling V̇O2max within a paediatric population. Notwithstanding the 348 
substantial support for both leg muscle mass and fat-free mass as denominators of V̇O2max [69], the 349 
diversity of physiological profiles within clinical and sports populations requires an independent holistic 350 
predictor of aerobic fitness. The concurrent declines of aerobic fitness and fat-free mass with aging and 351 
disease are well-documented [87-90]. Leg muscle mass appears to be a suitable body size descriptor in 352 
Association Football (soccer) [51], but on the other hand, upper-body musculature is a critical determinant 353 
of physical performance in sports like cross-country skiing [91, 92]. Therefore, fat-free mass should be 354 
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regarded as a more accurate reference standard for normalizing V̇O2max, irrespective of the examined 355 
population. 356 
We found a substantial sex-based difference of 0.24 (0.11 to 0.38) for the body mass exponent 357 
(Table 2). Previous studies have pointed out the importance of testing the commonality of size-exponent 358 
between sexes to avoid biases in the normalized indices [93, 94]. The main reason for the smaller exponent 359 
in females is likely due to their greater amount of adipose tissue compared with males [52]. On the 360 
contrary, our pooled exponent for fat-free mass was closer to a constant proportion, in both sexes (Table 3). 361 
Notably, the normalization of cardiovascular function in adult subjects [93] shows an identical pattern to 362 
that observed for energy metabolism [23, 64]. Since cardiac output is the major determinant of oxygen 363 
supply [95], the allometric relationship between left-ventricular mass [93] and both the considered scaling 364 
denominators for V̇O2max [23] are in line with the observed magnitudes (Fig. 2). The interconnection 365 
between fat-free mass and cardiovascular supply determines an additional line of evidence to account for 366 
differences not only in body size but particularly in body composition when comparing maximal aerobic 367 
capacity within heterogeneous samples [28, 79]. 368 
Not only do our results support the use of fat-free mass for routine normalisation of maximal 369 
aerobic metabolism in humans [86, 69], they are also consistent with the allometric cascade model [73]. 370 
For fat-free mass, the pooled b value of 0.90 and the high probability that the true exponents in future 371 
studies will be greater than ⅔- or ¾-power scaling thus appear to reflect the multi-level matching of energy 372 
supply and demand under aerobic conditions [75, 96]. If, contrary to the fact, body fatness were observed 373 
to be homogeneous between individuals across the examined cohort of studies, the exponents for whole-374 
body mass and fat-free mass would be identical. We interpret the deflation in the b value for whole-body 375 
mass as a statistical artefact that results from the concurrent inclusion in the model of non-contributing 376 
body proportions to maximal aerobic metabolism in humans. Our line of evidence, thus, substantiates a 377 
notion already advanced 60 years ago that the amount of body fat mass could spuriously affect the obtained 378 
size-exponent [30].  379 
 380 
5   Conclusions 381 
 382 
Our results indicate the adoption of an empirical approach, contrary to the proposed power laws, is 383 
paramount to derive size-independent indices of V̇O2max. The observed discrepancy in the magnitudes of 384 
the allometric exponents between whole-body mass and fat-free mass is likely the result of the lack of 385 
statistical adjustment for known confounders in the body mass studies, especially adipose tissue. Since the 386 
variation in energy supply appears to match the increasing demand towards maximal aerobic metabolism in 387 
the active tissues, it is important to account for body proportions that do not contribute to the work 388 
performed at vigorous intensity.  389 
 Our results provide large-scale empirical evidence against the normalization of V̇O2max to whole-390 
body mass and underline the validity of normalising to fat-free mass. Our large sample of study cohorts 391 
enabled a robust estimate of the expected range of true b values for fat-free mass in similar future studies, 392 
the magnitude of which is consistent with the allometric cascade model.  393 
 394 
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Table 1 Summary of characteristics of the thirty-six studies meeting the eligibility criteria  
Study n Population 
Age (years) Body size (kg) Body composition V̇O2max (L·min-1) Exercise testing 
Scaling denominator(s) 
Line-fitting 
Mean Mean assessment Mean mode method     
Amara et al. [32] 
152 Healthy men 68.7 78.2  
SSK 
1.78 
Treadmill Fat-free mass Log-linear 
146 Healthy women 70.0 63.8 1.21    
           
Armstrong et al. [22] 
106 Middle school boys 12.2 41.2  
SSK 
2.10 
Treadmill Body mass Log-linear 
106 Middle school girls 12.2 43.9 1.92    
          
Batterham and Jackson [44] 1629 Healthy men 45.0 78.8 SSK 3.09 Treadmill Fat-free mass Non-linear 
           
 26 Pre-pubertal boys 11.0 34.3 
- 
1.82    
Batterham et al. [45] 26 Teenage boys 14.1 49.5 2.60 Treadmill Body mass Log-linear 
 23 Healthy men 22.4 76.7 4.18    
           
Batterham et al. [23] 1314 Healthy men employed at NASA 44.6 79.2 SSK 3.08 Treadmill Body mass / fat-free mass Non-linear 
           
 
28 Middle school boys 11.7 40.1 
SSK 
2.09 Treadmill   
 
1.84 Cycle ergometer 
  
Bloxham et al. [46] 
    
Body mass Log-linear     
1.94 Treadmill  
28 Middle school girls 11.7 42.2  
   
  
1.69 Cycle ergometer 
  
         
           
Carvalho et al. [47] 37 Youth male basketball players 15.3 73.3 ADP 4.65 Treadmill Body mass / fat-free mass Log-linear 
           
Carvalho et al. [48] 30 Obese boys 13.0a 72.4 BIA 2.41 Treadmill Body mass / fat-free mass Log-linear 
           
Chamari et al. [33] 
24 Senior male football players 24.0 75.7  
SSK 
4.45 
Treadmill Fat-free mass Log-linear 
21 Youth male football players 14.0 60.2 3.60     
           
Chia and Aziz [49] 
158 Male athletes 21.7 64.8  
- 
3.73 
Treadmill Body mass Log-linear 
28 Female athletes 21.9 53.0 2.53     
           
 21 Healthy male adolescents 16.0 65.0 
- 
3.25a    
Cooper et al. [50] 
37 Healthy boys 10.0 34.0 1.43a 
Cycle ergometer Body mass Log-linear 
27 Healthy female adolescents 15.0 52.0 1.77a     
 24 Healthy girls 9.0 33.0 1.25a    
           
Cunha et al. [18] 
52 Pubescent youth male football players 13.4 62.5  
- 
3.72 
Treadmill Body mass Log-linear 
58 Post-pubescent youth male football players 17.0 73.9 4.45     
           
 14 Pre-pubescent youth male football players 13.3 55.0 
 
- 
3.45a    
Cunha et al. [51] 38 Pubescent youth male football players 15.3 68.0 4.16a Treadmill Body mass Log-linear 
 27 Post-pubescent youth male football players 16.4 74.7 4.35a    
           
Davies et al. [34] 73 Healthy ambulatory men 69.7 80.2 DXA 2.20 Treadmill Body mass / fat-free mass Log-linear 
           
 40 Pre- and early pubertal girls 9.2 33.8 
- 
1.44a    
Eliakim et al. [52] 22 
High-school girls 16.0a 
56.4 1.57 Cycle ergometer Body mass Non-linear 
 
22 60.3 1.48 
   
      
          
Table 1 Continued  
Study n Population 
Age (years) Body size (kg) Body composition V̇O2max (L·min-1) Exercise testing 
Scaling denominator(s) 
Line-fitting 
Mean Mean assessment Mean mode method     
Goosey-Tolfrey et al. [35] 
20 
Male wheelchair athletes 
27.0 67.9  
SSK 
2.35 
Wheelchair ergometer Fat-free mass Non-linear 
25 28.0 70.1 2.67      
           
Heil [24] 
210 Healthy men 45.6 81.8  
SSK 
3.54 
Treadmill Fat-free mass Log-linear 
230 Healthy women 47.5 64.7 2.14     
           
Jullien et al. [53] 13 Youth male football players 17.5a 65.0 - 
4.13a Treadmill 
Body mass Log-linear 
4.29a Cycle ergometer        
           
Markovic et al. [54] 
270 Male athletes 22.2 80.1 
- 
4.50 
Treadmill Body mass Log-linear 
43 Untrained men 21.7 78.0 3.90     
           
 9  29.5a 73.8 
 
 
 
SSK / DXA 
2.64    
 13 Healthy men (university staff) 49.5a 79.6 2.21    
Neder et al. [55] 
14  70.0a 74.9 1.58 
Cycle ergometer Fat-free mass Log-linear 
9 
 
29.5a 66.4 1.67      
 14 Healthy women (university staff) 49.5a 64.3   1.31    
 18  70.0a 62.5   1.06    
           
Nes et al. [56] 
281 Healthy male adolescents 15.7 66.7 
- 
3.92 
Treadmill Body mass Log-linear 
289 Healthy female adolescents 15.6 58.0 2.78     
           
Nevill et al. [58] 
98 International-standard male athletes 24.2 73.9  
SSK 
5.19a 
Treadmill / rowing ergometer Fat-free mass Log-linear 
76 International-standard female athletes 24.5 61.6 3.56a     
           
Nevill et al. [57] 36 Healthy circumpubertal boys 12.2 45.6 SSK 2.14a Cycle ergometer Body mass Log-linear 
           
 4  23.5 87.3 
SSK 
3.99a    
Nevill et al. [59] 
33 
Professional male football players 
22.1 78.9 4.34a 
Treadmill Body mass Log-linear 
64 22.0 75.3 4.37a        
 18  22.1 77.3   4.58a    
           
 11  8.5a 31.7 
- 
1.79    
 26  10.5a 35.4 2.00    
Pettersen et al. [25] 33 Healthy boys / adolescents 12.5a 46.8 2.56 Treadmill Body mass Log-linear 
 24  14.5a 57.3 3.47    
 13  16.5a 65.8 3.84    
           
Rogers et al. [60] 
21 Healthy boys 9.0 30.4  
SSK 
1.66 
Treadmill Body mass Log-linear 
21 Healthy girls 8.8 30.1 1.50     
          
Rowland et al. [61] 
24 Healthy girls 11.7 46.9  
SSK 
1.89a 
Cycle ergometer Body mass Log-linear 
17 Healthy young adult women 27.4 62.5 2.17a     
           
Table 1 Continued  
Study n Population 
Age (years) Body size (kg) Body composition V̇O2max (L·min-1) Exercise testing 
Scaling denominator(s) 
Line-fitting 
Mean Mean assessment Mean mode method     
Segers et al. [36] 
6 Early mature youth male football players 14.3 65.2  
SSK 
3.84 
Treadmill Fat-free mass Log-linear 
7 Late mature youth male football players 14.4 43.3 2.57    
           
Tartaruga et al. [62] 
11 Male long distance runners 22.3 61.7  
SSK 
3.40 Treadmill 
Body mass Log-linear 
15 Elite male rowers 24.0 83.5 5.10 Rowing ergometer    
           
Tolfrey et al. [37] 
15 Healthy boys 12.3 43.6  
SSK 
2.23 
Treadmill Body mass / fat-free mass Non-linear 
14 Healthy men 25.4 78.3 4.10     
           
 20  10.5 40.5   2.00    
Valente-Dos-Santos et al. [63] 31 Youth male football players 14.6 61.8 PE / DXA 3.33 Treadmill Body mass / fat-free mass Log-linear 
 30  17.4 69.7   3.83    
           
Vanderburgh and Katch [64] 94 Healthy women 27.4 60.3 UW 2.70 Treadmill Body mass / fat-free mass Log-linear 
           
 29 Late mature youth male football players 11.4 36.6 
- 
1.89    
Viickberg et al. [19] 26 Average mature youth male football players 11.2 39.0 2.02 Cycle ergometer Body mass Log-linear 
 9 Early mature youth male football players 10.8 42.7 2.14    
           
 29 Prepubertal boys 10.7 34.9 
- 
1.76    
 26 Circumpubertal male adolescents 14.1 49.5 2.60    
Welsman et al. [66] 
18 Male adults 22.8 78.6 4.18 
Treadmill Body mass Log-linear 
33 Prepubertal girls 10.7 32.7 1.48     
 34 Circumpubertal female adolescents 13.0 46.5 2.14    
 16 Female adults 21.7 60.5 2.58    
           
Welsman et al. [65] 
16 Middle school boys 9.9 32.0 
- 
1.95 
Treadmill Body mass Log-linear 
16 Middle school girls 9.9 35.5 1.81     
           
Wijndaele et al. [67] 
571 Men at risk of metabolic syndrome 46.7 79.5b 
 
 
 
BIA 
 
2.90 
Cycle ergometer Fat-free mass Log-linear 
448 Women at risk of metabolic syndrome 45.8 65.3b 1.80      
a : values derived from the available data; b : personal communication; ADP: Air-displacement plethysmography; BIA: Bioelectrical impedance analysis; DXA: Dual-energy X-ray absorptiometry; NASA: National Aeronautics and Space 
Adminstration Johnson Center; PE: Predictive equation; SSK: Sum-of-skinfolds; UW: Underwater weighing; V̇O2max: Maximal oxygen uptake 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 Allometric exponents for fat-free mass and the various potential moderator variables 
Moderator Subgroup n b 95% CL R2 
Age category Young 7 0.92 0.79 - 1.05 0.17 
Adult 11 0.90 0.82 - 0.98 
Mixed 2 0.81 0.65 - 0.98 
Sporting background Athletes 9 0.85 0.75 - 0.95 0.11 
Non-athletes 11 0.92 0.84 - 1.01 
Sex Male 14 0.89 0.80 - 0.98 0.00 
Female 3 0.94 0.75 - 1.13 
Mixed 3 0.88 0.73 - 1.03 
V̇O2max testing      
Criteria None 2 0.90 0.71 - 1.09 0.00 
Stated but unverified 12 0.88 0.79 - 0.97 
Stated and verified 6 0.93 0.80 - 1.06 
Mode Treadmill 14 0.90 0.82 - 0.99 0.00 
Cycle ergometer 4 0.87 0.71 - 1.04 
Other 2 0.90 0.68 - 1.11 
Body composition assessment Greater precision  
(e.g. MRI) 
4 0.95 0.76 - 1.14 0.00 
Lower precision  
(e.g. SSK) 
16 0.89 0.82 - 0.96 
Line-fitting method Log-linear 17 0.89 0.81 - 0.97 0.00 
Non-linear 3 0.93 0.77 - 1.09 
Model adjustment Univariate 11 0.93 0.82 - 1.04 0.00 
Multivariable 9 0.88 0.79 - 0.96 
b : allometric exponent; CL : confidence limits; n: number of effects; R2 : proportion of between-study variance explained 
by the moderator; MRI : magnetic resonance imaging; SSK : sum of skinfolds; V̇O2max : maximal oxygen uptake  
Table 2 Allometric exponents for whole-body mass and the various potential moderator variables 
Moderator Subgroup n b 95% CL R2 
Age category Young 19 0.71 0.62 - 0.79 0.00 
Adult 11 0.67 0.55 - 0.78 
Mixed 4 0.72 0.54 - 0.89 
Sporting background Athletes 14 0.71 0.61 - 0.81 0.00 
Non-athletes 20 0.69 0.61 - 0.76 
Sex Male 23 0.76 0.70 - 0.83 0.30 
Female 6 0.52 0.40 - 0.64 
Mixed 5 0.64 0.52 - 0.76 
V̇O2max testing      
Criteria None 1 0.76 0.10 - 1.42 0.02 
Stated but unverified 18 0.71 0.63 - 0.79 
Stated and verified 15 0.68 0.59 - 0.76 
Mode Treadmill 26 0.70 0.63 - 0.77 0.00 
Cycle ergometer 6 0.68 0.54 - 0.81 
Other 2 0.72 0.34 - 1.10 
Line-fitting method Log-linear 31 0.71 0.65 - 0.78 0.00 
Non-linear 3 0.55 0.35 - 0.75 
Model adjustment Univariate 22 0.67 0.59 - 0.75 0.02 
Multivariable 12 0.73 0.64 - 0.82 
b : allometric exponent;  CL : confidence limits; n: number of effects;  R2 : proportion of between-study variance explained 
by the moderator;  V̇O2max : maximal oxygen uptake 




